Evaluation of Radium-223 Dichloride in the Treatment of Castration-Resistant Prostate Adenocarcinoma with Symptomatic Bone Metastases

被引：0
|
作者：
Maestre-Cutillas, R. [1 ]
Sanchez-Tornero, A. M. [2 ]
Baz-Sanz, L. [1 ]
Rubio-Fernandez, G. [1 ]
Casas-Fernandez, L. [2 ]
Romero-Otero, M. [2 ]
Perez-Iruela, J. A. [1 ]
机构：
[1] Hosp Univ Ramon Y Cajal, Madrid, Spain
[2] Hosp Clin Univ Valencia, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0559
引用
收藏
页码：S652 / S652
页数：1
相关论文
共 50 条
  • [21] The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
    Liu, Alex J.
    Kosiorek, Heidi E.
    Ueberroth, Benjamin E.
    Jaeger, Ellen
    Ledet, Elisa
    Kendi, Ayse T.
    Tzou, Katherine
    Quevedo, Fernando
    Choo, Richard
    Moore, Cassandra N.
    Ho, Thai H.
    Singh, Parminder
    Keole, Sameer R.
    Wong, William W.
    Sartor, Oliver
    Bryce, Alan H.
    PROSTATE, 2022, 82 (12): : 1202 - 1209
  • [22] Treatment outcome of radium-223 treatment for castration-resistant prostate cancer and bone metastases at a single university hospital
    Takayama, T.
    Sugihara, T.
    Kameda, T.
    Yamazaki, M.
    Komatsubara, M.
    Kamei, J.
    Fujisaki, A.
    Ando, S.
    Fujimura, T.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2022, 20 (01): : 75 - 81
  • [23] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [24] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
  • [25] Nursing Management of Patients With Castration-Resistant Prostate Cancer Undergoing Radium-223 Dichloride Treatment
    Delacruz, Anthony
    Arauz, Gabrielle
    Curley, Tracy
    Lindo, Amabella
    Jensen, Trine
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (02) : E31 - E35
  • [26] Phase 3 study of radium-223 dichloride (Ra-223) in Asian patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets)
    Sun, Y.
    Shi, H.
    Chen, C. -H.
    Lee, J. L.
    Kang, T. W.
    Park, S. H.
    Wu, T. L.
    Ng, Q. S.
    Keam, B.
    Wong, S. C. A.
    Tay, M. H.
    Ding, Q.
    Li, F.
    Ng, D. C. E.
    Liu, X.
    Zhang, Z.
    Guo, J.
    ANNALS OF ONCOLOGY, 2015, 26 : 73 - 74
  • [27] Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
    Wakita, Naoto
    Hara, Takuto
    Suzuki, Kotaro
    Terakawa, Tomoaki
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    ANTICANCER RESEARCH, 2024, 44 (06) : 2627 - 2635
  • [28] Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
    Shore, Neal D.
    UROLOGY, 2015, 85 (04) : 717 - 724
  • [29] The impact of genetic mutations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
    Liu, Alex John
    Kosiorek, Heidi E.
    Ueberroth, Benjamin Edward
    Kendi, Ayse T.
    Tzou, Katherine S.
    Quevedo, Fernando
    Choo, Richard
    Moore, Cassandra N.
    Ho, Thai Huu
    Singh, Parminder
    Keole, Sameer R.
    Wong, William
    Bryce, Alan Haruo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Radium-223 systemic alpha-radiotherapy: targeted treatment of castration-resistant prostate cancer with bone metastases
    Volkova, M., I
    Olshanskaya, A. S.
    ONKOUROLOGIYA, 2019, 15 (02): : 134 - 142
12345